Hybridoma Workflow for Antibody Discovery

Hybridoma technology relies on identifying and expanding high-secreting clones, an approach that mirrors cell line development principles of monoclonality, viability, and screening for productivity.

This topic is a logical extension for cell line development researchers involved in antibody discovery, therapeutic screening, or early-stage biologics development where stable expansion of high-producing clones is essential.

Learn More about Hybridoma Workflow for Antibody Discovery